The Efficacy and Safety of Decitabine in Combination with ATRA, G-CSF and Low Dose Cytarabine(Dlaag Regimen)in Relapsed/Refractory Acute Myeloid Leukemia Not Suitable for Strong Chemotherapy : A Phase 2, Prospective, Single-Arm, Multicenter Study

被引：0
|
作者：
Yang, Li [1 ]
Liu, Ligen [2 ]
Zhao, Limin [1 ]
Lu, Yingting [1 ]
Zhang, Jing [1 ]
Sun, Lihua [3 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Hematol, Sch Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Hematol, Sch Med, Shanghai, Peoples R China
[3] Fudan Univ, Qingpu Branch, Dept Hematol, Zhongshan Hosp, Shanghai, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131671
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5108
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Aclarubicin, Low-Dose Cytarabine Combined With G-CSF (CAG) Regimen For Patients Previously Treated Or Ineligible For Intensive Chemotherapy With Acute Myeloid Leukemia and Myelodysplastic Syndrom: A Single Center Experience
    Minauchi, Koichiro
    Obara, Masato
    Ara, Takahide
    Shima, Kanako
    Yasumoto, Atsushi
    Nakata, Masanobu
    Ota, Shuichi
    Imai, Kiyotoshi
    Hirano, Teiichi
    Kiyama, Yoshio
    Ogasawara, Masahiro
    Kobayashi, Naoki
    Imamura, Masahiro
    BLOOD, 2013, 122 (21)
  • [42] RESULTS OF A PHASE 2, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY OF LENALIDOMIDE IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
    O'Brien, Maureen
    Alonzo, Todd
    Cooper, Todd
    Levine, John
    Brown, Patrick
    Slone, Tamra
    Benettaib, Bouchra
    Biserna, Noha
    Poon, Jennifer
    Quan, Jackie
    Simcock, Mathew
    Weiss, Daniel
    Zimmerman, Linda
    Kolb, Edward
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [43] Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study
    Xiaoyang Li
    Yuexin Dong
    Ya Li
    Ruibao Ren
    Wen Wu
    Hongming Zhu
    Yunxiang Zhang
    Jiong Hu
    Junmin Li
    BMC Cancer, 19
  • [44] Low-dose decitabine priming with intermediate-dose cytarabine followed by umbilical cord blood infusion as consolidation therapy for elderly patients with acute myeloid leukemia: a phase II single-arm study
    Li, Xiaoyang
    Dong, Yuexin
    Li, Ya
    Ren, Ruibao
    Wu, Wen
    Zhu, Hongming
    Zhang, Yunxiang
    Hu, Jiong
    Li, Junmin
    BMC CANCER, 2019, 19 (01)
  • [45] Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial
    Kadia, Tapan M.
    Cortes, Jorge
    Ravandi, Farhad
    Jabbour, Elias
    Konopleva, Marina
    Benton, Christopher B.
    Burger, Jan
    Sasaki, Koji
    Borthakur, Gautam
    DiNardo, Courtney D.
    Pemmaraju, Naveen
    Daver, Naval
    Ferrajoli, Alessandra
    Wang, Xuemei
    Patel, Keyur
    Jorgensen, Jeffrey L.
    Wang, Sa
    O'Brien, Susan
    Pierce, Sherry
    Tuttle, Carla
    Estrov, Zeev
    Verstovsek, Srdan
    Garcia-Manero, Guillermo
    Kantarjian, Hagop
    LANCET HAEMATOLOGY, 2018, 5 (09): : E411 - E421
  • [46] A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)
    Wrzesien-Kus, A
    Robak, T
    Lech-Maranda, E
    Wierzbowska, A
    Dmoszynska, A
    Kowal, M
    Holowiecki, J
    Kyrcz-Krzemien, S
    Grosicki, S
    Maj, S
    Hellmann, A
    Skotnicki, A
    Jedrzejczak, W
    Kuliczkowski, K
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (03) : 155 - 162
  • [47] Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
    Halpern, Anna B.
    Othus, Megan
    Huebner, Emily M.
    Scott, Bart L.
    Hendrie, Paul C.
    Percival, Mary-Elizabeth M.
    Becker, Pamela S.
    Smith, Heather A.
    Oehler, Vivian G.
    Orozco, Johnnie J.
    Cassaday, Ryan D.
    Gardner, Kelda M.
    Chen, Tara L.
    Buckley, Sarah A.
    Orlowski, Kaysey F.
    Anwar, Asma
    Estey, Elihu H.
    Walter, Roland B.
    HAEMATOLOGICA, 2019, 104 (04) : E143 - E146
  • [48] Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study
    Pau Montesinos
    Gail J. Roboz
    Claude-Eric Bulabois
    Marion Subklewe
    Uwe Platzbecker
    Yishai Ofran
    Cristina Papayannidis
    Agnieszka Wierzbowska
    Ho Jin Shin
    Vadim Doronin
    Stefan Deneberg
    Su-Peng Yeh
    Mehmet Ali Ozcan
    Steven Knapper
    Jorge Cortes
    Daniel A. Pollyea
    Gert Ossenkoppele
    Sergio Giralt
    Hartmut Döhner
    Michael Heuser
    Liang Xiu
    Indrajeet Singh
    Fei Huang
    Julie S. Larsen
    Andrew H. Wei
    Leukemia, 2021, 35 : 62 - 74
  • [49] Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study
    Montesinos, Pau
    Roboz, Gail J.
    Bulabois, Claude-Eric
    Subklewe, Marion
    Platzbecker, Uwe
    Ofran, Yishai
    Papayannidis, Cristina
    Wierzbowska, Agnieszka
    Shin, Ho Jin
    Doronin, Vadim
    Deneberg, Stefan
    Yeh, Su-Peng
    Ozcan, Mehmet Ali
    Knapper, Steven
    Cortes, Jorge
    Pollyea, Daniel A.
    Ossenkoppele, Gert
    Giralt, Sergio
    Doehner, Hartmut
    Heuser, Michael
    Xiu, Liang
    Singh, Indrajeet
    Huang, Fei
    Larsen, Julie S.
    Wei, Andrew H.
    LEUKEMIA, 2021, 35 (01) : 62 - 74
  • [50] Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
    Palmieri, Raffaele
    Buckley, Sarah A.
    Othus, Megan
    Halpern, Anna B.
    Percival, Mary-Elizabeth M.
    Scott, Bart L.
    Hendrie, Paul C.
    Becker, Pamela S.
    Oehler, Vivian G.
    Estey, Elihu H.
    Walter, Roland B.
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1728 - 1731
12345